World

FDA to scrutinize unproven cancer drugs after 10-year gap

Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button